PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | |hypertension |
| Sentences | 247 |
| PubMedID- 25191561 | In the second step we additionally adjustedfor bmi, hypertension, diabetes, dyslipidaemia, history of heart disease, smoking, incomeand education. |
| PubMedID- 26339897 | In ssc, because of the great variability in clinical manifestation, it is possible to identify pulmonary hypertension due to left heart disease, ph due to respiratory disease or pulmonary arterial hypertension. |
| PubMedID- 23829793 | Group 2 'pulmonary hypertension due to left heart diseases' is divided into three sub-groups: systolic dysfonction, diastolic dysfonction and valvular dysfonction. |
| PubMedID- 25672044 | Enlargement of right atrium is usually secondary to pulmonary hypertension due to valvular heart diseases or obstructive pulmonary disorders, atrial septal defect, tricuspid atresia or stenosis, pulmonary stenosis, primary pulmonary hypertension, ebstein's anomaly. |
| PubMedID- 25150487 | Decreased levels of serum angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease. |
| PubMedID- 23316284 | Hf risk factors including smoking history, diabetes, cerebrovascular disease, hypertension, and history of ischemic heart disease were determined via clinical chart review or the use of disease-specific medications (ie, antiglycemics or antihypertensive medications). |
| PubMedID- 22778912 | The authors of “management of hypertension among patients with coronary heart disease” concluded that in order to achieve a target bp in hypertensive patients with coronary heart disease of <130/80 effective combination therapy is required which includes a b-blocker, ace inhibitor or arb and possibly a thiazide diuretic. |
| PubMedID- 24987253 | The clinical characteristics of the study population including the referral diagnosis are listed in table 1. ventricular septal defect (vsd) was the most common congenital heart disease leading to pulmonary hypertension in this study. |
| PubMedID- 24294047 | Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease. |
| PubMedID- 21191432 | Pulmonary hypertension due to left-sided heart disease, hypoxemic lung disease, and thromboembolic disorders are each classified separately. |
| PubMedID- 20459681 | 3 years old female patient, known case of congenital heart disease with pulmonary hypertension and cerebral palsy was admitted to the hospital on 7th october 2009 with high grade of fever, cough, sore throat, difficulty in breathing and body aches. |
| PubMedID- 24093869 | Value of systolic right ventricular function parameters in children with pulmonary arterial hypertension associated with congenital heart diseases. |
| PubMedID- 23644116 | Objective: to investigate the correlation of g487a polymorphism of aldehyde dehydrogenase-2 (aldh2) gene with hypertension in patients with coronary heart disease complicated by type 2 diabetes. |
| PubMedID- 21763017 | Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. |
| PubMedID- 21802156 | Therapy for pulmonary arterial hypertension due to congenital heart disease and down's syndrome. |
| PubMedID- 25011987 | Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. |
| PubMedID- 21381322 | The objective of the present work was to develop methods and a scientifically sound rationale for the optimization of clinical results of the treatment of patients presenting with arterial hypertension (ah) associated with coronary heart disease (chd) using red and infra-red (ir) low-intensity laser irradiation. |
| PubMedID- 23015200 | No medical treatment has been established to ameliorate pulmonary hypertension (ph) due to left heart disease. |
| PubMedID- 25984322 | Heart samples were divided into 4 groups as follows: (1) 10 healthy donors without evidence of alcohol consumption, hypertension or other causes of heart disease (control group), (2) 16 non-alcoholic hypertensive donors, (3) 23 donors with chronic alcohol consumption and (4) 7 non-alcoholic donors with other causes of cardiac disease. |
| PubMedID- 24553088 | However, from recent trials, only hypertension with structural heart disease, left ventricular dysfunction and left ventricular hypertrophy benefit from aceis and arbs. |
| PubMedID- 20803971 | Pulmonary hypertension due to left heart disease, lung disease and/or hypoxia and cteph should be excluded from pah. |
| PubMedID- 20515628 | In patients with pulmonary hypertension due to left heart disease or lung disease, treatment focuses on the underlying condition and there is no convincing evidence that agents approved for pulmonary arterial hypertension are effective. |
| PubMedID- 25453535 | The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. |
| PubMedID- 25532374 | hypertension complicated with coronary heart disease, blood lipoprotein disorder disease; phlegm and blood stasis and yin deficiency of liver and kidney are the most in tcm syndrome type. |
| PubMedID- 22720870 | +: p < 0.05 in comparison to group 3, pulmonary hypertension owing to left heart disease (ph-lhd). |
| PubMedID- 20856682 | Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan. |
| PubMedID- 25881225 | Background: increased blood flow may trigger pulmonary arterial wall inflammation, which may influence progression of pulmonary artery hypertension in patients with congenital heart disease. |
| PubMedID- 25749848 | Compared with the older patients(>/= 45 years), the crude hazard ratio (hr) for nccl progression in the young patients(<45 years) was 2.17 (95% ci 1.42-3.30; p < 0.001); the association remained significant after adjustment for sex, st elevation myocardial infarction, body mass index, systolic and diastolic blood pressure, serum lipids, fasting blood glucose, smoking, drinking, hypertension, family history of coronary heart disease, diabetes mellitus, medication use and nccl characteristics (adjusted hr 1.70, 95% ci 1.06-2.72; p = 0.029). |
| PubMedID- 22081363 | Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease. |
| PubMedID- 23210355 | [artificial silicious-carbon dioxide baths for the rehabilitation and secondary prophylaxis in the patients presenting with arterial hypertension associated with coronary heart disease]. |
| PubMedID- 23573090 | Type 1 diabetes mellitus, hypertension, history of ischemic heart disease, renal impairment (serum creatinine > 150 umol/l), and valvular heart diseases were excluded. |
| PubMedID- 19958396 | Pulmonary arterial hypertension in adults with congenital heart disease. |
| PubMedID- 25911011 | Describes the quality of life (qol) in patients with pulmonary arterial hypertension (pah) due to congenital heart disease (chd) [1]. |
| PubMedID- 23204121 | Pulmonary arterial hypertension associated with congenital heart disease. |
| PubMedID- 25886600 | hypertension contributes to half of the coronary heart disease and approximately two-thirds of the cerebrovascular disease burdens [2]. |
| PubMedID- 21196769 | Background: patients with atherosclerotic renovascular disease (arvd) are at increased risk of heart disease because of associated hypertension, coronary artery disease, cardiac failure and chronic kidney disease. |
| PubMedID- 26509155 | Hypertensive heart disease, the leading cause of death from hypertension, causes left ventricular hypertrophy (lvh) through neural and humoral factors [3, 4]. |
| PubMedID- 20819756 | Increased resistance to pulmonary venous drainage is the main mechanism in pulmonary hypertension (ph) developing due to left heart disease. |
| PubMedID- 19766467 | It has been demonstrated that hypertension can lead to coronary heart disease, heart failure, stroke, and memory loss. |
| PubMedID- 25652796 | Background and aims: arterial hypertension doubles the risk of coronary heart disease, heart and kidney failure, and peripheral arterial disease. |
| PubMedID- 24561861 | Patients with pulmonary hypertension associated with congenital heart disease survive longer with preserved right ventricular (rv) function compared with those with primary pulmonary hypertension. |
| PubMedID- 25164216 | [research progress of pulmonary hypertension due to left heart disease]. |
| PubMedID- 20947817 | In multivariable regression analyses that adjusted for age, sex, smoking, hypertension, history of coronary heart disease/stroke, systolic blood pressure, and serum creatinine, nt pro-bnp levels remained significantly higher in patients with pca than in patients with pad and controls (p<0.001). |
| PubMedID- 22781765 | [screening study of pulmonary arterial hypertension in patients with congenital heart diseases]. |
| PubMedID- 22870905 | Furthermore, l-citrulline decreased pulmonary hypertension after surgery in patients with congenital heart disease [47], and it also reduced blood pressure response to cold stress [48]. |
| PubMedID- 26502478 | The most common cause of ph, termed group 2 ph, is left-sided heart failure and is commonly known as pulmonary hypertension with left heart disease (ph-lhd). |
| PubMedID- 20950484 | The mean gfr was statistically lower in elderly patients, in women, in patients with hypertension, diabetes, a history of heart diseases, heart failure, and a family history for stroke (table 2). |
| PubMedID- 25443244 | Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions. |
| PubMedID- 22876051 | These findings differed from previous report that old age, female gender, diabetes, hypertension, previous history of coronary heart disease or coronary intervention were associated with prolonged prehospital delay (19-23). |
| PubMedID- 20728407 | Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21. |